Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

August 2010; Volume 30,Issue 8

Proceedings of the 13th Annual Meeting of the Society of Biotherapeutic Approaches, December 5, 2009, Takamatsu, Japan.

  • You have access
    Preface
    Masamichi Tomonaga
    Anticancer Research August 2010, 30 (8) 3103;
  • You have access
    Emerging Strategies for ErbB Ligand-based Targeted Therapy for Cancer
    HIROSHI TSUJIOKA, FUSANORI YOTSUMOTO, KYOKO SHIROTA, SHINJI HORIUCHI, TOSHIYUKI YOSHIZATO, MASAHIDE KUROKI and SHINGO MIYAMOTO
    Anticancer Research August 2010, 30 (8) 3107-3112;
  • You have access
    Recovery from Immunosuppression-related Disorders in Humans and Animals by IP-PA1, An Edible Lipopolysaccharide
    TAKEHISA HEBISHIMA, YASUNOBU MATSUMOTO, GEN WATANABE, GEN-ICHIRO SOMA, CHIE KOHCHI, KAZUYOSHI TAYA, YOSHIHIRO HAYASHI and YOSHIKAZU HIROTA
    Anticancer Research August 2010, 30 (8) 3113-3118;
  • You have access
    Apoptosis as a Possible Candidate Mechanism for Removal of Tamoxifen-related Endometrial Cells with KRAS Mutations
    HIROSHI TSUJIOKA, TORU HACHISUGA, SHOKO HIKITA, TAEKO UEDA, FUSANORI YOTSUMOTO, KYOKO SHIROTA, TOSHIYUKI YOSHIZATO, TATSUHIKO KAWARABAYASHI, MASAHIDE KUROKI and SHINGO MIYAMOTO
    Anticancer Research August 2010, 30 (8) 3119-3123;
  • You have access
    Lymphokine-activated Killer Cell Therapy Combined with High-dose Glucocorticoid Showed Clinical Efficacy towards Advanced Lung Carcinoma
    MIKIO KATO, SHIGENORI GOTO and GEN-ICHIRO SOMA
    Anticancer Research August 2010, 30 (8) 3125-3128;
  • You have access
    Antitumor Effect of Inhalatory Lipopolysaccharide and Synergetic Effect in Combination with Cyclophosphamide
    KEIJI HIROTA, YUSUKE OISHI, HIROAKI TANIGUCHI, KEIICHI SAWACHI, HIROYUKI INAGAWA, CHIE KOHCHI, GEN-ICHIRO SOMA and HIROSHI TERADA
    Anticancer Research August 2010, 30 (8) 3129-3134;
  • You have access
    Cytotoxic Effects of Activated Alveolar Macrophages on Lung Carcinoma Cells via Cell-to-Cell Contact and Nitric Oxide
    KEIICHI SAWACHI, YASUTERU SHIMADA, HIROAKI TANIGUCHI, KEIJI HIROTA, HIROYUKI INAGAWA, CHIE KOHCHI, GEN-ICHIRO SOMA, KIMIKO MAKINO and HIROSHI TERADA
    Anticancer Research August 2010, 30 (8) 3135-3141;
  • You have access
    HB-EGF Inhibition in Combination with Various Anticancer Agents Enhances its Antitumor Effects in Gastric Cancer
    AYAKO SANUI, FUSANORI YOTSUMOTO, HIROSHI TSUJIOKA, TATSUYA FUKAMI, SHINJI HORIUCHI, KYOKO SHIROTA, TOSHIYUKI YOSHIZATO, TATSUHIKO KAWARABAYASHI, MASAHIDE KUROKI and SHINGO MIYAMOTO
    Anticancer Research August 2010, 30 (8) 3143-3149;
  • You have access
    Preparation of Lipopolysaccharide Derived from Pantoea agglomerans Labeled with Fluorescence as a Tracer for Kinetics Analysis
    TAKESHI KADOWAKI, HIROYUKI INAGAWA, CHIE KOHCHI, MITSUOMI HIRASHIMA and GEN-ICHIRO SOMA
    Anticancer Research August 2010, 30 (8) 3151-3157;
  • You have access
    Lipopolysaccharide-activated Alveolar Macrophages Having Cytotoxicity toward Lung Tumor Cells through Cell-to-Cell Binding-dependent Mechanism
    HIROAKI TANIGUCHI, YASUTERU SHIMADA, KEIICHI SAWACHI, KEIJI HIROTA, HIROYUKI INAGAWA, CHIE KOHCHI, GEN-ICHIRO SOMA, KIMIKO MAKINO and HIROSHI TERADA
    Anticancer Research August 2010, 30 (8) 3159-3165;
  • You have access
    Role of Lipid Rafts in Phagocytic Uptake of Polystyrene Latex Microspheres by Macrophages
    GOSHI NAGAO, KAZUO ISHII, KEIJI HIROTA, KIMIKO MAKINO and HIROSHI TERADA
    Anticancer Research August 2010, 30 (8) 3167-3176;
  • You have access
    N-Acetyl Transferase 2 Polymorphisms Associated with Isoniazid Pharmacodynamics: Molecular Features for Ligand Interaction
    KAZUTO OHKURA, KATSUMI FUKINO, YASUO SHINOHARA and HITOSHI HORI
    Anticancer Research August 2010, 30 (8) 3177-3180;
  • You have access
    Increased Claudin-1 Protein Expression Contributes to Tumorigenesis in Ulcerative Colitis-associated Colorectal Cancer
    TETSUSHI KINUGASA, YOSHITO AKAGI, TAKEFUMI YOSHIDA, YASUHIKO RYU, ICHITAROU SHIRATUCHI, NOBUYA ISHIBASHI and KAZUO SHIROUZU
    Anticancer Research August 2010, 30 (8) 3181-3186;
  • You have access
    WT1 Expression Correlates with Angiogenesis in Endometrial Cancer Tissue
    SATOSHI DOHI, SATOSHI OHNO, YUMIKO OHNO, SATORU KYO, GEN-ICHIRO SOMA, HARUO SUGIYAMA and MASAKI INOUE
    Anticancer Research August 2010, 30 (8) 3187-3192;
  • You have access
    Clinical Features of and Chemotherapy for Cancer of the Small Intestine
    DAIJIRO HIGASHI, YUKIKO ISHIBASHI, TOMOAKI TAMURA, KAORI NII, YUJI EGAWA, MASAKAZU KOGA, TAKASHIGE TOMIYASU, TAKANORI HARIMURA, RYOSUKE TANAKA, RYO FUTATSUKI, SIMPEI NODA, KITARO FUTAMI, TAKAFUMI MAEKAWA, YASUHIRO TAKAKI, FUMIHITO HIRAI and TOSHIYUKI MATSUI
    Anticancer Research August 2010, 30 (8) 3193-3197;
  • You have access
    A Retrospective Study of a Calcium Agent (E-Ca) Using Data on Bone Mineral Density Obtained by DXA Method
    RYOTA TAKEUCHI, YOSHIHIRO UTO, YOSHINORI NAKAGAWA, KEIJI HIROTA, HIROSHI TERADA and HITOSHI HORI
    Anticancer Research August 2010, 30 (8) 3199-3205;
  • You have access
    The Relationship between Clinicopathological Factors and the Reduction of Pyrimidine Nucleoside Phosphorylase Activity after Preoperative Administration of 5′-Deoxy-5-fluorouridine
    TERUKO HONDA, HIROYUKI INAGAWA, TAKASHI NISHIZAWA, HIROSHI YOSHIMURA, ISAMU YAMAMOTO and GEN-ICHIRO SOMA
    Anticancer Research August 2010, 30 (8) 3207-3211;

BOOK REVIEWS

  • You have access
    Book Reviews
    Anticancer Research August 2010, 30 (8) 3213;
  • You have access
    Cancer Nanotechnology. Methods and Protocols.
    Anticancer Research August 2010, 30 (8) 3213;
  • You have access
    Natural Killer Cell Protocols. Cellular and Molecular Methods.
    Anticancer Research August 2010, 30 (8) 3213;
  • You have access
    Cyclooxygenases. Methods and Protocols.
    Anticancer Research August 2010, 30 (8) 3213;
  • You have access
    Targeted Cancer Therapy.
    Anticancer Research August 2010, 30 (8) 3214;
  • You have access
    Advances in Chromatographic Techniques for Therapeutic Drug Monitoring.
    Anticancer Research August 2010, 30 (8) 3214;
  • You have access
    Textbook of Drug Design and Discovery. Fourth Edition.
    Anticancer Research August 2010, 30 (8) 3214;
  • You have access
    Industrial Biotechnology. Sustainable Growth and Economic Success.
    Anticancer Research August 2010, 30 (8) 3214-3215;
  • You have access
    Electrospray and MALDI Mass Spectrometry. Fundamentals, Instrumentation, Practicalities, and Biological Applications.
    Anticancer Research August 2010, 30 (8) 3215;
  • You have access
    Signal Processing in Magnetic Resonance Spectroscopy with Biomedical Applications.
    Anticancer Research August 2010, 30 (8) 3215;
  • You have access
    Handbook of Photonics for Biomedical Science.
    Anticancer Research August 2010, 30 (8) 3215-3216;
  • You have access
    Handbook of Anatomical Models for Radiation Dosimetry.
    Anticancer Research August 2010, 30 (8) 3216;
  • You have access
    Protein Discovery Technologies.
    Anticancer Research August 2010, 30 (8) 3216;
  • You have access
    Instrumental Analysis of Intrinsically Disordered Proteins. Assessing Structure and Conformation.
    Anticancer Research August 2010, 30 (8) 3216-3217;
  • You have access
    Flow Cytometry in Neoplastic Hematology. Morphologic – Immunophenotypic Correlation.
    Anticancer Research August 2010, 30 (8) 3217;
  • You have access
    Image-Guided Radiation Therapy in Lymphoma Management. The Increasing Role of Functional Imaging.
    Anticancer Research August 2010, 30 (8) 3217;
  • You have access
    Lung Cancer. Prevention, Management, and Emerging Therapies.
    Anticancer Research August 2010, 30 (8) 3217;
  • You have access
    Protein Misfolding in Neurodegenerative Diseases. Mechanisms and Therapeutic Strategies.
    Anticancer Research August 2010, 30 (8) 3217-3218;
  • You have access
    Breast Cancer Epidemiology.
    Anticancer Research August 2010, 30 (8) 3218;
  • You have access
    Managing Infections in Patients with Hematological Malignancies.
    Anticancer Research August 2010, 30 (8) 3218;
  • You have access
    Cancer and IgE. Introducing the Concept of AllergoOncology.
    Anticancer Research August 2010, 30 (8) 3218;
  • You have access
    Myeloma Bone Disease.
    Anticancer Research August 2010, 30 (8) 3218-3219;
  • You have access
    The Biochemsitry of Drug Metabolism: Principles, Redox Reactions, Hydrolyses; The Biochemsitry of Drug Metabolism: Conjugations, Consequences of Metabolism, Influencing Factors.
    Anticancer Research August 2010, 30 (8) 3219;
  • You have access
    Personalized Nutrition. Translating Nutrigenetic / Nutrigenomic Research into Dietary Guidelines.
    Anticancer Research August 2010, 30 (8) 3219;
  • You have access
    Human Molecular Genetics. 4th Edition.
    Anticancer Research August 2010, 30 (8) 3219;
  • You have access
    The Mandsley Prescribing Guidelines. 10th Edition.
    Anticancer Research August 2010, 30 (8) 3219;
  • You have access
    Handbook of Physics in Medicine and Biology.
    Anticancer Research August 2010, 30 (8) 3219-3220;
  • You have access
    Introduction to Proteomics. Principles and Applications.
    Anticancer Research August 2010, 30 (8) 3220;
  • You have access
    IARC Monographs on the Evaluation of Carcinogenic. Risks to Humans.
    Anticancer Research August 2010, 30 (8) 3220;
  • You have access
    Biopharmaceuticals in Plants. Toward the Next Century Medicine.
    Anticancer Research August 2010, 30 (8) 3220;
  • You have access
    Cancer in Numbers.
    Anticancer Research August 2010, 30 (8) 3220;
  • You have access
    Cancer Genome and Tumor Microenviroment.
    Anticancer Research August 2010, 30 (8) 3221;
  • You have access
    Quantitative Drug Design. A Critical Introduction.
    Anticancer Research August 2010, 30 (8) 3221;
  • You have access
    Understanding Leukemias, Lymphomas and Myelomas. Second Edition.
    Anticancer Research August 2010, 30 (8) 3221;
  • You have access
    IARC Monographs on the Evaluation of Carcinogenic Risks to Humans.
    Anticancer Research August 2010, 30 (8) 3221;
  • You have access
    Debating Human Genetics. Contemporary Issues in Public Policy and Ethics.
    Anticancer Research August 2010, 30 (8) 3221;
Back to top
PreviousNext

In this issue

Anticancer Research
Vol. 30, Issue 8
August 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • BOOK REVIEWS
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire